Literature DB >> 1304418

Prevalence of physiological valvular regurgitation in hypertensive patients: echocardiographic and color Doppler study.

L Lonati1, C Cuspidi, L Sampieri, L Boselli, M Bocciolone, G Leonetti, A Zanchetti.   

Abstract

Since the advent of the Doppler color flow echocardiography, the presence of a small degree of insufficiency of the cardiac valves has been detected with relative frequency in structurally and functionally normal hearts. Data about this so-called 'physiological' regurgitation are presently available only in normotensive subjects and athletes. We therefore studied the prevalence of this phenomenon in a group of patients with essential hypertension compared to a population of normotensive subjects. To this purpose, a Doppler color flow echocardiographic study was performed in 130 essential hypertensive patients (72M/58F; age 44.2 +/- 13.5 years; BP 154.3 +/- 12.8/98.3 +/- 7.1 mm Hg) without any evidence of left ventricular hypertrophy or cardiopathy and in 100 normal subjects (59M/41F; age 41.2 +/- 14.8 years; BP 119.1 +/- 8.1/79.2 +/- 8.1 mm Hg). We conclude that in patients with essential hypertension the physiological regurgitant jets are present in one or more cardiac valves; moreover, the regurgitation of the mitral and aortic valve is found with more frequency than in the normotensive control group (36.1 vs. 27.0% and 17.7 vs. 11.0%, respectively). These data suggest that the increased afterload of the left ventricle may play an important role in the pathogenesis of even minor degree of insufficiency of the cardiac valves. As this finding does not appear to have a pathological relevance, the main clinical implication of this study is that it is not advisable to create a jatrogenic heart disease in the hypertensive patients routinely screened by the echo-Doppler technique.

Entities:  

Mesh:

Year:  1992        PMID: 1304418     DOI: 10.1159/000175830

Source DB:  PubMed          Journal:  Cardiology        ISSN: 0008-6312            Impact factor:   1.869


  4 in total

Review 1.  Drug Therapy for Heart Valve Diseases.

Authors:  Jeffrey S Borer; Abhishek Sharma
Journal:  Circulation       Date:  2015-09-15       Impact factor: 29.690

2.  Ankylosing spondylitis and heart abnormalities: do cardiac conduction disorders, valve regurgitation and diastolic dysfunction occur more often in male patients with diagnosed ankylosing spondylitis for over 15 years than in the normal population?

Authors:  Florian Brunner; Andres Kunz; Ulrich Weber; Rudolf Kissling
Journal:  Clin Rheumatol       Date:  2005-10-25       Impact factor: 2.980

3.  Echocardiographic Findings in Patients with Atrial Septal Aneurysm: A Prospective Case-Control Study.

Authors:  Ramazan Atak; Mehmet Ileri; Selcuk Ozturk; Ahmet Korkmaz; Ertan Yetkin
Journal:  Cardiol Res Pract       Date:  2019-04-01       Impact factor: 1.866

4.  Frequency and Clinical Associating Factors of Valvular Heart Disease in Asymptomatic Korean Adults.

Authors:  Min Sun Kim; Soo Jin Cho; Sung-Ji Park; Sung Won Cho; Soo-Hee Choi; Hye Seung Kim; Keumhee Carriere; Eun Kyoung Kim; Sung-A Chang; Sang-Chol Lee; Seung Woo Park
Journal:  Sci Rep       Date:  2019-11-14       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.